Literature DB >> 12082457

Selective killing of cancer cells based on translational control of a suicide gene.

Robert J DeFatta1, Yuan Li, Arrigo De Benedetti.   

Abstract

The translation initiation factor, eIF4E, is commonly overexpressed in solid tumors. This elevation allows for efficient translation of mRNA that are normally repressed by their 5' untranslated region, many of which encode growth-promoting proteins. This property was exploited to modulate the synthesis of HTK at the translational level to selectively kill cancer cells. Various breast cancer cell lines can efficiently synthesize HTK from the translationally regulated mRNA, whereas normal cells cannot. Accordingly, only cancer cells were killed at low concentrations of ganciclovir. By altering the expression of eIF4E, it was possible to modulate the sensitivity of various cell lines to ganciclovir.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082457     DOI: 10.1038/sj.cgt.7700468

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  8 in total

Review 1.  Targeted polymeric nanoparticles for cancer gene therapy.

Authors:  Jayoung Kim; David R Wilson; Camila G Zamboni; Jordan J Green
Journal:  J Drug Target       Date:  2015-06-10       Impact factor: 5.121

2.  The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro.

Authors:  Belinda Westman; Lisa Beeren; Ewa Grudzien; Janusz Stepinski; Remigiusz Worch; Joanna Zuberek; Jacek Jemielity; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads; Thomas Preiss
Journal:  RNA       Date:  2005-08-30       Impact factor: 4.942

Review 3.  eIF4E: new family members, new binding partners, new roles.

Authors:  Robert E Rhoads
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

4.  A programmable NOR-based device for transcription profile analysis.

Authors:  Tom Ran; Yehonatan Douek; Lilach Milo; Ehud Shapiro
Journal:  Sci Rep       Date:  2012-09-07       Impact factor: 4.379

5.  Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting.

Authors:  Yu Xiang Fang; Xiao Bo Zhang; Wei Wei; Yi Wen Liu; Jin Zhong Chen; Jing Lun Xue; Ling Tian
Journal:  Mol Biotechnol       Date:  2010-05       Impact factor: 2.695

Review 6.  Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?

Authors:  Gert C Scheper; Christopher G Proud
Journal:  Eur J Biochem       Date:  2002-11

7.  Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects.

Authors:  Jia Li; Guiying Zhang; Ting Liu; Huan Gu; Lu Yan; Bolin Chen
Journal:  Exp Ther Med       Date:  2012-06-18       Impact factor: 2.447

Review 8.  The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.

Authors:  Sara Karaki; Claudia Andrieu; Hajer Ziouziou; Palma Rocchi
Journal:  Adv Protein Chem Struct Biol       Date:  2015-10-23       Impact factor: 3.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.